Search

everythinglearnresearchcommunity

for

Search:↓

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

Nonclassic congenital adrenal hyperplasia is a common genetic disorder that can cause a range of symptoms and requires personalized treatment.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

The conclusion is to diagnose PCOS with just hyperandrogenism and irregular periods, and treat with lifestyle changes and basic medications.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

More research is needed to understand how testosterone is maintained in adult males.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.